The concern that cumulative radiation exposure over a lifetime of healthcare-related imaging could boost the risk of cancer is addressed in the latest launch from GE Healthcare ($GE). It's rolled out DoseWatch Explore to track practice-level radiation dose data from its computed tomography (CT) systems.
The cloud-based management software tracks, analyzes and reports this data to help practices improve patient radiation dose levels during CT scans. It enables doctors to conduct a new level of analysis on this kind of data.
"Patient safety is at the heart of dose management and is a big driver for why we created this solution," said Agnes Berzsenyi, VP & GM of product development for global services at GE Healthcare, in a statement.
"For healthcare clinicians interested in managing radiation dose for CT, DoseWatch Explore is a perfect entry-level dose management solution that harnesses the power of data, analytics, and software to help clinicians achieve optimal dose levels and provide better patient care."
DoseWatch uses the cloud technology Microsoft Azure and is compatible with its own InSite connection. It collects radiation data directly from a GE CT scanner. The software can provide an analysis based on protocol parameters per exam and per device.
That's expected to help physicians to better manage radiation dose levels during these procedures. And, unlike other solutions, DoseWatch doesn't require any additional technology infrastructure or installation, since it sits at the level of the CT system.
"DoseWatch Explore is a great example of how integrated device, software and cloud platform solutions seamlessly work together to deliver practical, actionable insights to health organizations," said Neil Jordan, GM of worldwide health at Microsoft ($MSFT), in a statement. "Azure provides industry-leading security features and complies with a number of global, regional, and industry-specific standards and regulations, enabling providers using DoseWatch Explore to focus on their primary objective--improving patient health."
- here is the release